Definitions
from The American Heritage® Dictionary of the English Language, 5th Edition.
- noun An oral drug of the triptan class, C15H19N5, used in its benzoate form to treat migraine headaches.
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun medicine A
triptan agonist used in the treatment ofmigraine
Etymologies
from The American Heritage® Dictionary of the English Language, 4th Edition
Support
Help support Wordnik (and make this page ad-free) by adopting the word rizatriptan.
Examples
-
Although medications called triptans, such as rizatriptan (Maxalt) or sumatriptan (Imitrex), can often halt a migraine in progress, nearly half of migraine sufferers who take those or other pain-relieving drugs are still dissatisfied with their ability to function or work afterward.
-
Although medications called triptans, such as rizatriptan (Maxalt) or sumatriptan (Imitrex), can often halt a migraine in progress, nearly half of migraine sufferers who take those or other pain-relieving drugs are still dissatisfied with their ability to function or work afterward.
-
She finds that taking the migraine drug rizatriptan—usually taken only after the headache starts—can ward it off.
Beware, a Big Headache Is Coming Melinda Beck 2011
-
She finds that taking the migraine drug rizatriptan—usually taken only after the headache starts—can ward it off.
Beware, a Big Headache Is Coming Melinda Beck 2011
-
When a migraine hits I usually reach for a drug to stop it like sumatriptan (Imitrex) or rizatriptan (Maxalt).
Zapping migraines 2010
-
When a migraine hits I usually reach for a drug to stop it like sumatriptan (Imitrex) or rizatriptan (Maxalt).
Zapping migraines 2010
-
Global sales of MAXALT rizatriptan benzoate, Merck's tablet for the acute treatment of migraine, were $149 million for the fourth quarter of 2010, a 5 percent decrease from the same quarter last year.
unknown title 2011
-
Global sales of MAXALT (rizatriptan benzoate), Merck's tablet for the treatment of acute migraine, were $156 million for the fourth quarter of 2009, an 11 percent increase from the same quarter last year.
-
Global sales of MAXALT (rizatriptan benzoate), Merck's tablet for the treatment of acute migraine, were $156 million for the fourth quarter of 2009, an 11 percent increase from the same quarter last year.
THE MEDICAL NEWS Editors 2010
-
Global sales of MAXALT (rizatriptan benzoate), Merck's tablet for the treatment of acute migraine, were $156 million for the fourth quarter of 2009, an 11 percent increase from the same quarter last year.
THE MEDICAL NEWS Editors 2010
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.